TEST BANK FOR
PHARMACOLOGY AND THE NURSING PROCESS 10TH EDITION
BY LINDA LILLEY, SHELLY COLLINS, JULIE SNYDER CHAPTER 1-58 |COMPLETE ANSWERS
,Table of Contents
Chapter 01: The Nursing Process And Drug Therapy .................................................................................. 4
Chapter 02: Pharmacologic Principles ............................................................................................................ 8
Chapter 03: Lifespan Considerations .............................................................................................................. 16
Chapter 04: Cultural, Legal, And Ethical Considerations ......................................................................... 23
Chapter 05: Medication Errors: Preventing And Responding ................................................................. 30
Chapter 06: Patient Education And Drug Therapy ...................................................................................... 34
Chapter 07: Over-The-Counter Drugs And Herbal And Dietary Supplements ................................... 41
Chapter 08: Gene Therapy And Pharmacogenomics ................................................................................. 48
Chapter 09: Photo Atlas Of Drug Administration ........................................................................................ 54
Chapter 10: Analgesic Drugs ............................................................................................................................. 69
Chapter 11: General And Local Anesthetics .................................................................................................. 79
Chapter 12: Central Nervous System Depressants And Muscle Relaxants ....................................... 84
Chapter 13: Central Nervous System Stimulants And Related Drugs ................................................. 90
Chapter 14: Antiepileptic Drugs ........................................................................................................................ 95
Chapter 15: Antiparkinson Drugs .................................................................................................................... 101
Chapter 16: Psychotherapeutic Drugs ...........................................................................................................106
Chapter 17: Substance Use Disorder ............................................................................................................. 114
Chapter 18: Adrenergic Drugs.......................................................................................................................... 119
Chapter 19: Adrenergic-Blocking Drugs .......................................................................................................125
Chapter 20: Cholinergic Drugs ........................................................................................................................ 131
Chapter 21: Cholinergic-Blocking Drugs ...................................................................................................... 137
Chapter 22: Antihypertensive Drugs............................................................................................................. 142
Chapter 23: Antianginal Drugs........................................................................................................................ 150
Chapter 24: Heart Failure Drugs.....................................................................................................................160
Chapter 25: Antidysrhythmic Drugs ............................................................................................................... 169
Chapter 26: Coagulation Modifier Drugs ......................................................................................................178
Chapter 27: Antilipemic Drugs ........................................................................................................................ 188
Chapter 28: Diuretic Drugs ............................................................................................................................... 196
Chapter 29: Fluids And Electrolytes ............................................................................................................ 204
Chapter 30: Pituitary Drugs ..............................................................................................................................210
Chapter 31: Thyroid And Antithyroid Drugs................................................................................................. 214
Chapter 32: Diabetes Drugs............................................................................................................................. 220
,Chapter 33: Adrenal Drugs .............................................................................................................................. 230
Chapter 34: Women’s Health Drugs .............................................................................................................. 235
Chapter 35: Men’s Health Drugs ....................................................................................................................243
Chapter 36: Antihistamines, Decongestants, Antitussives, And Expectorants .............................. 248
Chapter 37: Respiratory Drugs ....................................................................................................................... 253
Chapter 38: Antibiotics Part 1.......................................................................................................................... 260
Chapter 39: Antibiotics Part 2 ......................................................................................................................... 268
Chapter 40: Antiviral Drugs ............................................................................................................................. 273
Chapter 41: Antitubercular Drugs .................................................................................................................. 279
Chapter 42: Antifungal Drugs ........................................................................................................................ 284
Chapter 43: Antimalarial, Antiprotozoal, And Anthelmintic Drugs ..................................................... 290
Chapter 44: Anti-Inflammatory And Antigout Drugs ............................................................................... 295
Chapter 45: Antineoplastic Drugs Part 1: Cancer Overview And Cell Cycle-Specific Drugs ...... 301
Chapter 46: Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific Drugs And Miscellaneous
Drugs ..................................................................................................................................................................... 308
Chapter 47: Biologic Response–Modifying And Antirheumatic Drugs ............................................... 314
Chapter 48: Immunosuppressant Drugs ......................................................................................................319
Chapter 49: Immunizing Drugs ....................................................................................................................... 325
Chapter 50: Acid-Controlling Drugs .............................................................................................................330
Chapter 51: Bowel Disorder Drugs ................................................................................................................ 337
Chapter 52: Antiemetic And Antinausea Drugs ........................................................................................ 345
Chapter 53: Vitamins And Minerals............................................................................................................... 351
Chapter 54: Anemia Drugs.............................................................................................................................. 358
Chapter 55: Nutritional Supplements ........................................................................................................... 366
Chapter 56: Dermatologic Drugs .................................................................................................................... 371
Chapter 57: Ophthalmic Drugs........................................................................................................................ 377
Chapter 58: Otic Drugs ......................................................................................................................................383
,Chapter 01: The Nursing Process And Drug Therapy
MULTIPLE CHOICE
1. The Nurse Is Developing A Human Needs Statement For A Patient Who Has A New Diagnosis
Of Heart Failure. Identification Of Human Needs Statements Occur With Which Of These
Activities?
A. Collection Of Patient Data
B. Administering Interventions
C. Deciding On Patient Outcomes
D. Documenting The Patient‘S Behavior
CORRECT ANSWER:A
Identification Of Human Needs Occurs With The Collection Of Patient Data.
DIF: Cognitive Level: Understanding (Comprehension)
TOP: Nursing Process: Human Needs Statement
MSC: NCLEX: Safe And Effective Care Environment: Management Of Care
2. The Patient Is To Receive Oral Guaifenesin Twice A Day. Today, The Nurse Was Busy And
Gave The Medication 2 Hours After The Scheduled Dose Was Due. What Type Of Problem Does
This Represent?
A. ―Right Time‖
B. ―Right Dose‖
C. ―Right Route‖
D. ―Right Medication‖
CORRECT ANSWER:A
Right Time‖ Is Correct Because The Medication Was Given More Than 30 Minutes After The
Scheduled Dose Was Due. Dose‖ Is Incorrect Because The Dose Is Not Related To The Time
The Medication Administration Is Scheduled. Route‖ Is Incorrect Because The Route Is Not
Affected.
Medication‖ Is Incorrect Because The Medication Ordered Will Not Change.
DIF: Cognitive Level: Applying (Application)
TOP: Nursing Process: Implementation
MSC: NCLEX: Safe And Effective Care Environment: Safety And Infection Control
,3. The Nurse Has Been Monitoring The Patient‘S Progress On A New Drug Regimen Since The
First Dose And Documenting The Patient‘S Therapeutic Response To The Medication. Which
Phase Of The Nursing Process Do These Actions Illustrate?
A. Human Needs Statement
B. Planning
C. Implementation
D. Evaluation
CORRECT ANSWER:D
Monitoring The Patient‘S Progress, Including The Patient‘S Response To The Medication, Is Part
Of The Evaluation Phase. Planning, Implementation, And Human Needs Statement Are Not
Illustrated By This Example.
DIF: Cognitive Level: Understanding (Comprehension)
TOP: Nursing Process: Evaluation
MSC: NCLEX: Safe And Effective Care Environment: Management Of Care
4. The Nurse Is Assigned To A Patient Who Is Newly Diagnosed With Type 1 Diabetes Mellitus.
Which Statement Best Illustrates An Outcome Criterion For This Patient?
A. The Patient Will Follow Instructions.
B. The Patient Will Not Experience Complications.
C. The Patient Will Adhere To The New Insulin Treatment Regimen.
D. The Patient Will Demonstrate Correct Blood Glucose Testing Technique.
CORRECT ANSWER:D
Demonstrating Correct Blood Glucose Testing Technique‖ Is A Specific And Measurable
Outcome Criterion. Following Instructions‖ And Not Experiencing Complications‖ Are Not
Specific Criteria. Adhering To New Regimen‖ Would Be Difficult To Measure.
DIF: Cognitive Level: Applying (Application) TOP: Nursing Process: Planning MSC:
NCLEX: Safe And Effective Care Environment: Management Of Care
5. Which Activity Best Reflects The Implementation Phase Of The Nursing Process For The
Patient Who Is Newly Diagnosed With Hypertension?
A. Providing Education On Keeping A Journal Of Blood Pressure Readings
B. Setting Goals And Outcome Criteria With The Patient‘S Input
,C. Recording A Drug History Regarding Over-The-Counter Medications Used At Home
D. Formulating Human Needs Statements Regarding Deficient Knowledge Related To The
New Treatment Regimen
CORRECT ANSWER:A
Education Is An Intervention That Occurs During The Implementation Phase. Setting Goals And
Outcomes Reflects The Planning Phase. Recording A Drug History Reflects The Assessment
Phase. Formulating Human Needs Statements Reflects Analysis Of Data As Part Of Planning.
DIF: Cognitive Level: Applying (Application) TOP: Nursing Process: Implementation
MSC: NCLEX: Safe And Effective Care Environment: Management Of Care
6. The Medication Order Reads, ―Give Ondansetron 4 Mg, 30 Minutes Before Beginning
Chemotherapy To Prevent Nausea.‖ The Nurse Notes That The Route Is Missing From The
Order. What Is The Nurse‘S Best Action?
A. Give The Medication Intravenously Because The Patient Might Vomit.
B. Give The Medication Orally Because The Tablets Are Available In 4-Mg Doses.
C. Contact The Prescriber To Clarify The Route Of The Medication Ordered.
D. Hold The Medication Until The Prescriber Returns To Make Rounds.
CORRECT ANSWER:C
A Complete Medication Order Includes The Route Of Administration. If A Medication Order Does
Not Include The Route, The Nurse Must Ask The Prescriber To Clarify It. The Intravenous And
Oral Routes Are Not Interchangeable. Holding The Medication Until The Prescriber Returns
Would Mean That The Patient Would Not Receive A Needed Medication.
DIF: Cognitive Level: Applying (Application)
TOP: Nursing Process: Implementation
MSC: NCLEX: Safe And Effective Care Environment: Management Of Care
7. When The Nurse Considers The Timing Of A Drug Dose, Which Factor Is Appropriate To
Consider When Deciding When To Give A Drug?
A. The Patient‘S Ability To Swallow
B. The Patient‘S Height
C. The Patient‘S Last Meal
D. The Patient‘S Allergies
,CORRECT ANSWER:C
The Nurse Must Consider Specific Pharmacokinetic/Pharmacodynamic Drug Properties That
May Be Affected By The Timing Of The Last Meal. The Patient‘S Ability To Swallow, Height, And
Allergies Are Not Factors To Consider Regarding The Timing Of The Drug‘S Administration.
DIF: Cognitive Level: Understanding (Comprehension)
TOP: Nursing Process: Assessment
MSC: NCLEX: Safe And Effective Care Environment: Management Of Care
8. The Nurse Is Performing An Assessment Of A Newly Admitted Patient. Which Is An Example
Of Subjective Data?
A. Weight 155 Pounds
B. Pulse 72 Beats/Minute
C. The Patient Reports That He Uses The Herbal Product Ginkgo
D. The Patient‘S Complete Blood Count Results
CORRECT ANSWER:C
Subjective Data Include Information Shared Through The Spoken Word By Any Reliable Source,
Such As The Patient. Objective Data May Be Defined As Any Information Gathered Through The
Senses Or That Which Is Seen, Heard, Felt, Or Smelled. A Patient‘S Pulse, Weight, And
Laboratory Tests Are All Examples Of Objective Data.
DIF: Cognitive Level: Understanding (Comprehension)
TOP: Nursing Process: Assessment
MSC: NCLEX: Safe And Effective Care Environment: Management Of Care
MULTIPLE RESPONSE
1. When Giving Medications, The Nurse Will Follow The Rights Of Medication Administration. The
Rights Include The Right Documentation, The Right Reason, The Right Response, And The
Patient‘S Right To Refuse. Which Of These Are Additional Rights? (Select All That Apply.)
A. Right Drug
B. Right Route
C. Right Dose
D. Right Diagnosis
E. Right Time
,F. Right Patient
CORRECT ANSWER:A, B, C, E, F
Additional Rights Of Medication Administration Must Always Include The Right Drug, Right
Dose, Right Time, Right Route, And Right Patient. The Right Diagnosis Is Incorrect.
DIF: Cognitive Level: Remembering (Knowledge)
TOP: Nursing Process: Implementation
MSC: NCLEX: Safe And Effective Care Environment: Safety And Infection Control
OTHER
1. Place The Phases Of The Nursing Process In The Correct Order, With 1 As The First
Phase And 5 As The Last Phase.
A. Planning
B. Evaluation
C. Assessment
D. Implementation
E. Human Needs Statement
CORRECT ANSWER:C, E, A, D, B
The Nursing Process Is An Ongoing Process That Begins With Assessing And Continues With
Human Needs Statement, Planning, Implementing, And Evaluating.
DIF: Cognitive Level: Applying (Application)
TOP: Nursing Process: General
MSC: NCLEX: Safe And Effective Care Environment: Management Of Care
Chapter 02: Pharmacologic Principles
MULTIPLE CHOICE
1. The Patient Is Receiving Two Different Drugs. At Current Dosages And Dosage Forms, Both
Drugs Have The Same Concentration Of The Active Ingredient. Which Term Is Used To Identify
This Principle?
,A. Bioequivalent
B. Synergistic
C. Prodrugs
D. Steady State
CORRECT ANSWER:A
Two Drugs Absorbed Into The Circulation In The Same Amount (In Specific Dosage Forms)
Have The Same Bioavailability; Thus, They Are Bioequivalent. A Drug‘S Steady State Is The
Physiologic State In Which The Amount Of Drug Removed Via Elimination Is Equal To The
Amount Of Drug Absorbed From Each Dose. The Term Synergistic Refers To Two Drugs, Given
Together, With A Resulting Effect That Is Greater Than The Sum Of The Effects Of Each Drug
Given Alone. A Prodrug Is An Inactive Drug Dosage Form That Is Converted To An Active
Metabolite By Various Biochemical Reactions Once It Is Inside The Body.
DIF: Cognitive Level: Understanding (Comprehension)
TOP: Nursing Process: Implementation
MSC: NCLEX: Physiological Integrity: Pharmacological And Parenteral Therapies
2. When Given An Intravenous Medication, The Patient Says To The Nurse, ―I Usually Take
Pills. Why Does This Medication Have To Be Given In The Arm?‖ What Is The Nurse‘S
Best Answer?
A. The Medication Will Cause Fewer Adverse Effects When Given Intravenously.‖
B. The Intravenous Medication Will Have Delayed Absorption Into The Body‘S Tissues.‖
C. The Action Of The Medication Will Begin Sooner When Given Intravenously.‖
D. There Is A Lower Chance Of Allergic Reactions When Drugs Are Given Intravenously.‖
CORRECT ANSWER:C
An Intravenous (IV) Injection Provides The Fastest Route Of Absorption. The IV Route Does Not
Affect The Number Of Adverse Effects, Nor Does It Cause Delayed Tissue Absorption (It
Results In Faster Absorption). The IV Route Does Not Affect The Number Of Allergic Reactions.
DIF: Cognitive Level: Understanding (Comprehension)
TOP: Nursing Process: Implementation
MSC: NCLEX: Physiological Integrity: Pharmacological And Parenteral Therapies
, 3. The Nurse Is Administering Parenteral Drugs. Which Statement Is True Regarding Parenteral
Drugs?
A. Parenteral Drugs Bypass The First-Pass Effect.
B. Absorption Of Parenteral Drugs Is Affected By Reduced Blood Flow To The Stomach.
C. Absorption Of Parenteral Drugs Is Faster When The Stomach Is Empty.
D. Parenteral Drugs Exert Their Effects While Circulating In The Bloodstream.
CORRECT ANSWER:A
Drugs Given By The Parenteral Route Bypass The First-Pass Effect. Reduced Blood Flow To
The Stomach And The Presence Of Food In The Stomach Apply To Enteral Drugs (Taken Orally),
Not To Parenteral Drugs. Parenteral Drugs Must Be Absorbed Into Cells And Tissues From The
Circulation Before They Can Exert Their Effects; They Do Not Exert Their Effects While
Circulating In The Bloodstream.
DIF: Cognitive Level: Understanding (Comprehension)
TOP: Nursing Process: General
MSC: NCLEX: Physiological Integrity: Pharmacological And Parenteral Therapies
4. When Monitoring The Patient Receiving An Intravenous Infusion To Reduce Blood Pressure,
The Nurse Notes That The Patient‘S Blood Pressure Is Extremely Low, And The Patient Is
Lethargic And Difficult To Awaken. This Would Be Classified As Which Type Of Adverse Drug
Reaction?
A. Adverse Effect
B. Allergic Reaction
C. Idiosyncratic Reaction
D. Pharmacologic Reaction
CORRECT ANSWER:D
A Pharmacologic Reaction Is An Extension Of A Drug‘S Normal Effects In The Body. In This
Case, The Antihypertensive Drug Lowered The Patient‘S Blood Pressure Levels Too Much. The
Other Options Do Not Describe A Pharmacologic Reaction. An Adverse Effect Is A Predictable,
Well-Known Adverse Drug Reaction That Results In Minor Or No Changes In Patient
Management. An Allergic Reaction (Also Known As A Hypersensitivity Reaction) Involves The
Patient‘S Immune System. An Idiosyncratic Reaction Is Unexpected And Is Defined As A
Genetically Determined Abnormal Response To Normal Dosages Of A Drug.
DIF: Cognitive Level: Understanding (Comprehension)
TOP: Nursing Process: General
PHARMACOLOGY AND THE NURSING PROCESS 10TH EDITION
BY LINDA LILLEY, SHELLY COLLINS, JULIE SNYDER CHAPTER 1-58 |COMPLETE ANSWERS
,Table of Contents
Chapter 01: The Nursing Process And Drug Therapy .................................................................................. 4
Chapter 02: Pharmacologic Principles ............................................................................................................ 8
Chapter 03: Lifespan Considerations .............................................................................................................. 16
Chapter 04: Cultural, Legal, And Ethical Considerations ......................................................................... 23
Chapter 05: Medication Errors: Preventing And Responding ................................................................. 30
Chapter 06: Patient Education And Drug Therapy ...................................................................................... 34
Chapter 07: Over-The-Counter Drugs And Herbal And Dietary Supplements ................................... 41
Chapter 08: Gene Therapy And Pharmacogenomics ................................................................................. 48
Chapter 09: Photo Atlas Of Drug Administration ........................................................................................ 54
Chapter 10: Analgesic Drugs ............................................................................................................................. 69
Chapter 11: General And Local Anesthetics .................................................................................................. 79
Chapter 12: Central Nervous System Depressants And Muscle Relaxants ....................................... 84
Chapter 13: Central Nervous System Stimulants And Related Drugs ................................................. 90
Chapter 14: Antiepileptic Drugs ........................................................................................................................ 95
Chapter 15: Antiparkinson Drugs .................................................................................................................... 101
Chapter 16: Psychotherapeutic Drugs ...........................................................................................................106
Chapter 17: Substance Use Disorder ............................................................................................................. 114
Chapter 18: Adrenergic Drugs.......................................................................................................................... 119
Chapter 19: Adrenergic-Blocking Drugs .......................................................................................................125
Chapter 20: Cholinergic Drugs ........................................................................................................................ 131
Chapter 21: Cholinergic-Blocking Drugs ...................................................................................................... 137
Chapter 22: Antihypertensive Drugs............................................................................................................. 142
Chapter 23: Antianginal Drugs........................................................................................................................ 150
Chapter 24: Heart Failure Drugs.....................................................................................................................160
Chapter 25: Antidysrhythmic Drugs ............................................................................................................... 169
Chapter 26: Coagulation Modifier Drugs ......................................................................................................178
Chapter 27: Antilipemic Drugs ........................................................................................................................ 188
Chapter 28: Diuretic Drugs ............................................................................................................................... 196
Chapter 29: Fluids And Electrolytes ............................................................................................................ 204
Chapter 30: Pituitary Drugs ..............................................................................................................................210
Chapter 31: Thyroid And Antithyroid Drugs................................................................................................. 214
Chapter 32: Diabetes Drugs............................................................................................................................. 220
,Chapter 33: Adrenal Drugs .............................................................................................................................. 230
Chapter 34: Women’s Health Drugs .............................................................................................................. 235
Chapter 35: Men’s Health Drugs ....................................................................................................................243
Chapter 36: Antihistamines, Decongestants, Antitussives, And Expectorants .............................. 248
Chapter 37: Respiratory Drugs ....................................................................................................................... 253
Chapter 38: Antibiotics Part 1.......................................................................................................................... 260
Chapter 39: Antibiotics Part 2 ......................................................................................................................... 268
Chapter 40: Antiviral Drugs ............................................................................................................................. 273
Chapter 41: Antitubercular Drugs .................................................................................................................. 279
Chapter 42: Antifungal Drugs ........................................................................................................................ 284
Chapter 43: Antimalarial, Antiprotozoal, And Anthelmintic Drugs ..................................................... 290
Chapter 44: Anti-Inflammatory And Antigout Drugs ............................................................................... 295
Chapter 45: Antineoplastic Drugs Part 1: Cancer Overview And Cell Cycle-Specific Drugs ...... 301
Chapter 46: Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific Drugs And Miscellaneous
Drugs ..................................................................................................................................................................... 308
Chapter 47: Biologic Response–Modifying And Antirheumatic Drugs ............................................... 314
Chapter 48: Immunosuppressant Drugs ......................................................................................................319
Chapter 49: Immunizing Drugs ....................................................................................................................... 325
Chapter 50: Acid-Controlling Drugs .............................................................................................................330
Chapter 51: Bowel Disorder Drugs ................................................................................................................ 337
Chapter 52: Antiemetic And Antinausea Drugs ........................................................................................ 345
Chapter 53: Vitamins And Minerals............................................................................................................... 351
Chapter 54: Anemia Drugs.............................................................................................................................. 358
Chapter 55: Nutritional Supplements ........................................................................................................... 366
Chapter 56: Dermatologic Drugs .................................................................................................................... 371
Chapter 57: Ophthalmic Drugs........................................................................................................................ 377
Chapter 58: Otic Drugs ......................................................................................................................................383
,Chapter 01: The Nursing Process And Drug Therapy
MULTIPLE CHOICE
1. The Nurse Is Developing A Human Needs Statement For A Patient Who Has A New Diagnosis
Of Heart Failure. Identification Of Human Needs Statements Occur With Which Of These
Activities?
A. Collection Of Patient Data
B. Administering Interventions
C. Deciding On Patient Outcomes
D. Documenting The Patient‘S Behavior
CORRECT ANSWER:A
Identification Of Human Needs Occurs With The Collection Of Patient Data.
DIF: Cognitive Level: Understanding (Comprehension)
TOP: Nursing Process: Human Needs Statement
MSC: NCLEX: Safe And Effective Care Environment: Management Of Care
2. The Patient Is To Receive Oral Guaifenesin Twice A Day. Today, The Nurse Was Busy And
Gave The Medication 2 Hours After The Scheduled Dose Was Due. What Type Of Problem Does
This Represent?
A. ―Right Time‖
B. ―Right Dose‖
C. ―Right Route‖
D. ―Right Medication‖
CORRECT ANSWER:A
Right Time‖ Is Correct Because The Medication Was Given More Than 30 Minutes After The
Scheduled Dose Was Due. Dose‖ Is Incorrect Because The Dose Is Not Related To The Time
The Medication Administration Is Scheduled. Route‖ Is Incorrect Because The Route Is Not
Affected.
Medication‖ Is Incorrect Because The Medication Ordered Will Not Change.
DIF: Cognitive Level: Applying (Application)
TOP: Nursing Process: Implementation
MSC: NCLEX: Safe And Effective Care Environment: Safety And Infection Control
,3. The Nurse Has Been Monitoring The Patient‘S Progress On A New Drug Regimen Since The
First Dose And Documenting The Patient‘S Therapeutic Response To The Medication. Which
Phase Of The Nursing Process Do These Actions Illustrate?
A. Human Needs Statement
B. Planning
C. Implementation
D. Evaluation
CORRECT ANSWER:D
Monitoring The Patient‘S Progress, Including The Patient‘S Response To The Medication, Is Part
Of The Evaluation Phase. Planning, Implementation, And Human Needs Statement Are Not
Illustrated By This Example.
DIF: Cognitive Level: Understanding (Comprehension)
TOP: Nursing Process: Evaluation
MSC: NCLEX: Safe And Effective Care Environment: Management Of Care
4. The Nurse Is Assigned To A Patient Who Is Newly Diagnosed With Type 1 Diabetes Mellitus.
Which Statement Best Illustrates An Outcome Criterion For This Patient?
A. The Patient Will Follow Instructions.
B. The Patient Will Not Experience Complications.
C. The Patient Will Adhere To The New Insulin Treatment Regimen.
D. The Patient Will Demonstrate Correct Blood Glucose Testing Technique.
CORRECT ANSWER:D
Demonstrating Correct Blood Glucose Testing Technique‖ Is A Specific And Measurable
Outcome Criterion. Following Instructions‖ And Not Experiencing Complications‖ Are Not
Specific Criteria. Adhering To New Regimen‖ Would Be Difficult To Measure.
DIF: Cognitive Level: Applying (Application) TOP: Nursing Process: Planning MSC:
NCLEX: Safe And Effective Care Environment: Management Of Care
5. Which Activity Best Reflects The Implementation Phase Of The Nursing Process For The
Patient Who Is Newly Diagnosed With Hypertension?
A. Providing Education On Keeping A Journal Of Blood Pressure Readings
B. Setting Goals And Outcome Criteria With The Patient‘S Input
,C. Recording A Drug History Regarding Over-The-Counter Medications Used At Home
D. Formulating Human Needs Statements Regarding Deficient Knowledge Related To The
New Treatment Regimen
CORRECT ANSWER:A
Education Is An Intervention That Occurs During The Implementation Phase. Setting Goals And
Outcomes Reflects The Planning Phase. Recording A Drug History Reflects The Assessment
Phase. Formulating Human Needs Statements Reflects Analysis Of Data As Part Of Planning.
DIF: Cognitive Level: Applying (Application) TOP: Nursing Process: Implementation
MSC: NCLEX: Safe And Effective Care Environment: Management Of Care
6. The Medication Order Reads, ―Give Ondansetron 4 Mg, 30 Minutes Before Beginning
Chemotherapy To Prevent Nausea.‖ The Nurse Notes That The Route Is Missing From The
Order. What Is The Nurse‘S Best Action?
A. Give The Medication Intravenously Because The Patient Might Vomit.
B. Give The Medication Orally Because The Tablets Are Available In 4-Mg Doses.
C. Contact The Prescriber To Clarify The Route Of The Medication Ordered.
D. Hold The Medication Until The Prescriber Returns To Make Rounds.
CORRECT ANSWER:C
A Complete Medication Order Includes The Route Of Administration. If A Medication Order Does
Not Include The Route, The Nurse Must Ask The Prescriber To Clarify It. The Intravenous And
Oral Routes Are Not Interchangeable. Holding The Medication Until The Prescriber Returns
Would Mean That The Patient Would Not Receive A Needed Medication.
DIF: Cognitive Level: Applying (Application)
TOP: Nursing Process: Implementation
MSC: NCLEX: Safe And Effective Care Environment: Management Of Care
7. When The Nurse Considers The Timing Of A Drug Dose, Which Factor Is Appropriate To
Consider When Deciding When To Give A Drug?
A. The Patient‘S Ability To Swallow
B. The Patient‘S Height
C. The Patient‘S Last Meal
D. The Patient‘S Allergies
,CORRECT ANSWER:C
The Nurse Must Consider Specific Pharmacokinetic/Pharmacodynamic Drug Properties That
May Be Affected By The Timing Of The Last Meal. The Patient‘S Ability To Swallow, Height, And
Allergies Are Not Factors To Consider Regarding The Timing Of The Drug‘S Administration.
DIF: Cognitive Level: Understanding (Comprehension)
TOP: Nursing Process: Assessment
MSC: NCLEX: Safe And Effective Care Environment: Management Of Care
8. The Nurse Is Performing An Assessment Of A Newly Admitted Patient. Which Is An Example
Of Subjective Data?
A. Weight 155 Pounds
B. Pulse 72 Beats/Minute
C. The Patient Reports That He Uses The Herbal Product Ginkgo
D. The Patient‘S Complete Blood Count Results
CORRECT ANSWER:C
Subjective Data Include Information Shared Through The Spoken Word By Any Reliable Source,
Such As The Patient. Objective Data May Be Defined As Any Information Gathered Through The
Senses Or That Which Is Seen, Heard, Felt, Or Smelled. A Patient‘S Pulse, Weight, And
Laboratory Tests Are All Examples Of Objective Data.
DIF: Cognitive Level: Understanding (Comprehension)
TOP: Nursing Process: Assessment
MSC: NCLEX: Safe And Effective Care Environment: Management Of Care
MULTIPLE RESPONSE
1. When Giving Medications, The Nurse Will Follow The Rights Of Medication Administration. The
Rights Include The Right Documentation, The Right Reason, The Right Response, And The
Patient‘S Right To Refuse. Which Of These Are Additional Rights? (Select All That Apply.)
A. Right Drug
B. Right Route
C. Right Dose
D. Right Diagnosis
E. Right Time
,F. Right Patient
CORRECT ANSWER:A, B, C, E, F
Additional Rights Of Medication Administration Must Always Include The Right Drug, Right
Dose, Right Time, Right Route, And Right Patient. The Right Diagnosis Is Incorrect.
DIF: Cognitive Level: Remembering (Knowledge)
TOP: Nursing Process: Implementation
MSC: NCLEX: Safe And Effective Care Environment: Safety And Infection Control
OTHER
1. Place The Phases Of The Nursing Process In The Correct Order, With 1 As The First
Phase And 5 As The Last Phase.
A. Planning
B. Evaluation
C. Assessment
D. Implementation
E. Human Needs Statement
CORRECT ANSWER:C, E, A, D, B
The Nursing Process Is An Ongoing Process That Begins With Assessing And Continues With
Human Needs Statement, Planning, Implementing, And Evaluating.
DIF: Cognitive Level: Applying (Application)
TOP: Nursing Process: General
MSC: NCLEX: Safe And Effective Care Environment: Management Of Care
Chapter 02: Pharmacologic Principles
MULTIPLE CHOICE
1. The Patient Is Receiving Two Different Drugs. At Current Dosages And Dosage Forms, Both
Drugs Have The Same Concentration Of The Active Ingredient. Which Term Is Used To Identify
This Principle?
,A. Bioequivalent
B. Synergistic
C. Prodrugs
D. Steady State
CORRECT ANSWER:A
Two Drugs Absorbed Into The Circulation In The Same Amount (In Specific Dosage Forms)
Have The Same Bioavailability; Thus, They Are Bioequivalent. A Drug‘S Steady State Is The
Physiologic State In Which The Amount Of Drug Removed Via Elimination Is Equal To The
Amount Of Drug Absorbed From Each Dose. The Term Synergistic Refers To Two Drugs, Given
Together, With A Resulting Effect That Is Greater Than The Sum Of The Effects Of Each Drug
Given Alone. A Prodrug Is An Inactive Drug Dosage Form That Is Converted To An Active
Metabolite By Various Biochemical Reactions Once It Is Inside The Body.
DIF: Cognitive Level: Understanding (Comprehension)
TOP: Nursing Process: Implementation
MSC: NCLEX: Physiological Integrity: Pharmacological And Parenteral Therapies
2. When Given An Intravenous Medication, The Patient Says To The Nurse, ―I Usually Take
Pills. Why Does This Medication Have To Be Given In The Arm?‖ What Is The Nurse‘S
Best Answer?
A. The Medication Will Cause Fewer Adverse Effects When Given Intravenously.‖
B. The Intravenous Medication Will Have Delayed Absorption Into The Body‘S Tissues.‖
C. The Action Of The Medication Will Begin Sooner When Given Intravenously.‖
D. There Is A Lower Chance Of Allergic Reactions When Drugs Are Given Intravenously.‖
CORRECT ANSWER:C
An Intravenous (IV) Injection Provides The Fastest Route Of Absorption. The IV Route Does Not
Affect The Number Of Adverse Effects, Nor Does It Cause Delayed Tissue Absorption (It
Results In Faster Absorption). The IV Route Does Not Affect The Number Of Allergic Reactions.
DIF: Cognitive Level: Understanding (Comprehension)
TOP: Nursing Process: Implementation
MSC: NCLEX: Physiological Integrity: Pharmacological And Parenteral Therapies
, 3. The Nurse Is Administering Parenteral Drugs. Which Statement Is True Regarding Parenteral
Drugs?
A. Parenteral Drugs Bypass The First-Pass Effect.
B. Absorption Of Parenteral Drugs Is Affected By Reduced Blood Flow To The Stomach.
C. Absorption Of Parenteral Drugs Is Faster When The Stomach Is Empty.
D. Parenteral Drugs Exert Their Effects While Circulating In The Bloodstream.
CORRECT ANSWER:A
Drugs Given By The Parenteral Route Bypass The First-Pass Effect. Reduced Blood Flow To
The Stomach And The Presence Of Food In The Stomach Apply To Enteral Drugs (Taken Orally),
Not To Parenteral Drugs. Parenteral Drugs Must Be Absorbed Into Cells And Tissues From The
Circulation Before They Can Exert Their Effects; They Do Not Exert Their Effects While
Circulating In The Bloodstream.
DIF: Cognitive Level: Understanding (Comprehension)
TOP: Nursing Process: General
MSC: NCLEX: Physiological Integrity: Pharmacological And Parenteral Therapies
4. When Monitoring The Patient Receiving An Intravenous Infusion To Reduce Blood Pressure,
The Nurse Notes That The Patient‘S Blood Pressure Is Extremely Low, And The Patient Is
Lethargic And Difficult To Awaken. This Would Be Classified As Which Type Of Adverse Drug
Reaction?
A. Adverse Effect
B. Allergic Reaction
C. Idiosyncratic Reaction
D. Pharmacologic Reaction
CORRECT ANSWER:D
A Pharmacologic Reaction Is An Extension Of A Drug‘S Normal Effects In The Body. In This
Case, The Antihypertensive Drug Lowered The Patient‘S Blood Pressure Levels Too Much. The
Other Options Do Not Describe A Pharmacologic Reaction. An Adverse Effect Is A Predictable,
Well-Known Adverse Drug Reaction That Results In Minor Or No Changes In Patient
Management. An Allergic Reaction (Also Known As A Hypersensitivity Reaction) Involves The
Patient‘S Immune System. An Idiosyncratic Reaction Is Unexpected And Is Defined As A
Genetically Determined Abnormal Response To Normal Dosages Of A Drug.
DIF: Cognitive Level: Understanding (Comprehension)
TOP: Nursing Process: General
